-
1
-
-
76149111947
-
Inflammatory lipid mediators in adipocyte function and obesity
-
Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D. et al., Inflammatory lipid mediators in adipocyte function and obesity. Nat. Rev. Endocrinol. 2010, 6, 71-82.
-
(2010)
Nat. Rev. Endocrinol.
, vol.6
, pp. 71-82
-
-
Iyer, A.1
Fairlie, D.P.2
Prins, J.B.3
Hammock, B.D.4
-
2
-
-
34247851021
-
The epidemiology of obesity
-
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., Flegal, K. M., The epidemiology of obesity. Gastroenterology 2007, 132, 2087-2102.
-
(2007)
Gastroenterology
, vol.132
, pp. 2087-2102
-
-
Ogden, C.L.1
Yanovski, S.Z.2
Carroll, M.D.3
Flegal, K.M.4
-
3
-
-
38949108241
-
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
-
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569-578.
-
(2008)
Lancet
, vol.371
, pp. 569-578
-
-
Renehan, A.G.1
Tyson, M.2
Egger, M.3
Heller, R.F.4
-
4
-
-
30044439080
-
Epidemiologic and economic consequences of the global epidemics of obesity and diabetes
-
Yach, D., Stuckler, D., Brownell, K. D., Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat. Med. 2006, 12, 62-66.
-
(2006)
Nat. Med.
, vol.12
, pp. 62-66
-
-
Yach, D.1
Stuckler, D.2
Brownell, K.D.3
-
5
-
-
43049096057
-
Adipokines and the peripheral and neural control of energy balance
-
Ahima, R. S., Lazar, M. A., Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 2008, 22, 1023-1031.
-
(2008)
Mol. Endocrinol.
, vol.22
, pp. 1023-1031
-
-
Ahima, R.S.1
Lazar, M.A.2
-
6
-
-
58149499174
-
Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases
-
Yamauchi, T., Kadowaki, T., Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond.) 2008, 32, S13-S18.
-
(2008)
Int. J. Obes. (Lond.)
, vol.32
-
-
Yamauchi, T.1
Kadowaki, T.2
-
7
-
-
80655145234
-
Clinical review#: lipodystrophies: genetic and acquired body fat disorders
-
Garg, A., Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J. Clin. Endocrinol. Metab. 2011, 96, 3313-3325.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 3313-3325
-
-
Garg, A.1
-
8
-
-
46049103645
-
Dietary regulation of nuclear receptors in obesity-related metabolic syndrome
-
Kawada, T., Goto, T., Hirai, S., Kang, M. S., Uemura, T. et al., Dietary regulation of nuclear receptors in obesity-related metabolic syndrome. Asia Pac. J. Clin. Nutr. 2008, 17, 126-130.
-
(2008)
Asia Pac. J. Clin. Nutr.
, vol.17
, pp. 126-130
-
-
Kawada, T.1
Goto, T.2
Hirai, S.3
Kang, M.S.4
Uemura, T.5
-
9
-
-
84858029073
-
Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity
-
Guyenet, S. J., Schwartz, M. W., Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J. Clin. Endocrinol. Metab. 2012, 97, 745-755.
-
(2012)
J. Clin. Endocrinol. Metab.
, vol.97
, pp. 745-755
-
-
Guyenet, S.J.1
Schwartz, M.W.2
-
10
-
-
33749017409
-
The human obesity gene map: the 2005 update
-
Rankinen, T., Zuberi, A., Changnon, Y. C., Weisnagel, S. J. et al., The human obesity gene map: the 2005 update. Obesity 2006, 14, 529-644.
-
(2006)
Obesity
, vol.14
, pp. 529-644
-
-
Rankinen, T.1
Zuberi, A.2
Changnon, Y.C.3
Weisnagel, S.J.4
-
11
-
-
9144223683
-
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
-
Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 1821-1830
-
-
Xu, H.1
Barnes, G.T.2
Yang, Q.3
Tan, G.4
-
12
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
-
13
-
-
14544305075
-
The human adipose tissue is a source of multipotent stem cells
-
Rodriguez, A. M., Elabd, C., Amri, E. Z., Ailhaud, G. et al., The human adipose tissue is a source of multipotent stem cells. Biochimie 2005, 87, 125-128.
-
(2005)
Biochimie
, vol.87
, pp. 125-128
-
-
Rodriguez, A.M.1
Elabd, C.2
Amri, E.Z.3
Ailhaud, G.4
-
14
-
-
20444475450
-
The transcriptional basis of adipocyte development
-
Rosen, E. D., The transcriptional basis of adipocyte development. Prostaglandin Leukot. Essent. Fatty Acids 2005, 73, 31-34.
-
(2005)
Prostaglandin Leukot. Essent. Fatty Acids
, vol.73
, pp. 31-34
-
-
Rosen, E.D.1
-
15
-
-
80054911514
-
Forming functional fat: a growing understanding of adipocyte differentiation
-
Cristancho, A. G., Lazar, M. A., Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 2011, 12, 722-734.
-
(2011)
Nat. Rev. Mol. Cell Biol.
, vol.12
, pp. 722-734
-
-
Cristancho, A.G.1
Lazar, M.A.2
-
16
-
-
78449258535
-
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways
-
Abdelkarim, M., Caron, S., Duhem, C., Prawitt, J. et al., The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. J. Biol. Chem. 2010, 285, 36759-36767.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 36759-36767
-
-
Abdelkarim, M.1
Caron, S.2
Duhem, C.3
Prawitt, J.4
-
17
-
-
11144356074
-
Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression
-
Seo, J. B., Moon, H. M., Kim, W. S., Lee, Y. S. et al., Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 2004, 24, 3430-3444.
-
(2004)
Mol. Cell. Biol.
, vol.24
, pp. 3430-3444
-
-
Seo, J.B.1
Moon, H.M.2
Kim, W.S.3
Lee, Y.S.4
-
18
-
-
79954989984
-
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
-
Goto, T., Lee, J. Y., Teraminami, A., Kim, Y. I. et al., Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J. Lipid Res. 2011, 52, 873-884.
-
(2011)
J. Lipid Res.
, vol.52
, pp. 873-884
-
-
Goto, T.1
Lee, J.Y.2
Teraminami, A.3
Kim, Y.I.4
-
19
-
-
79960823883
-
Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist
-
Goto, T., Nagai, H., Egawa, K., Kim, Y. I. et al., Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem. J. 2011, 438, 111-119.
-
(2011)
Biochem. J.
, vol.438
, pp. 111-119
-
-
Goto, T.1
Nagai, H.2
Egawa, K.3
Kim, Y.I.4
-
20
-
-
0033574663
-
A unified nomenclature system for the nuclear receptor superfamily
-
Nuclear Receptor Nomenclature Committee.
-
Nuclear Receptor Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999, 97, 161-163.
-
(1999)
Cell
, vol.97
, pp. 161-163
-
-
-
21
-
-
33644636344
-
Going nuclear in metabolic and cardiovascular disease
-
Glass, C. K., Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 2006, 116, 556-560.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 556-560
-
-
Glass, C.K.1
-
22
-
-
33751548984
-
Overview of nomenclature of nuclear receptors
-
Germain, P., Staels, B., Dacquet, C., Spedding, M. et al., Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006, 58, 685-704.
-
(2006)
Pharmacol. Rev.
, vol.58
, pp. 685-704
-
-
Germain, P.1
Staels, B.2
Dacquet, C.3
Spedding, M.4
-
23
-
-
67650230627
-
Genome science of lipid metabolism and obesity
-
Takahashi, N., Goto, T., Hirai, S., Uemura, T. et al., Genome science of lipid metabolism and obesity. Forum Nutr. 2009, 61, 25-38.
-
(2009)
Forum Nutr.
, vol.61
, pp. 25-38
-
-
Takahashi, N.1
Goto, T.2
Hirai, S.3
Uemura, T.4
-
24
-
-
77954568426
-
Various terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism
-
Goto, T., Takahashi, N., Hirai, S., Kawada, T., Various terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism. PPAR Res. 2010, 2010, 483958.
-
(2010)
PPAR Res.
, vol.2010
, pp. 483958
-
-
Goto, T.1
Takahashi, N.2
Hirai, S.3
Kawada, T.4
-
25
-
-
77951901129
-
Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics
-
Huang, P., Chandra, V., Rastinejad, F., Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu. Rev. Physiol. 2010, 72, 247-272.
-
(2010)
Annu. Rev. Physiol.
, vol.72
, pp. 247-272
-
-
Huang, P.1
Chandra, V.2
Rastinejad, F.3
-
26
-
-
0035099604
-
Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors
-
Lee, J. W., Lee, Y. C., Na, S. Y., Jung, D. J. et al., Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell. Mol. Life Sci. 2001, 58, 289-297.
-
(2001)
Cell. Mol. Life Sci.
, vol.58
, pp. 289-297
-
-
Lee, J.W.1
Lee, Y.C.2
Na, S.Y.3
Jung, D.J.4
-
27
-
-
1942518840
-
PPARs and the complex journey to obesity
-
Evans, R. M., Barish, G. D., Wang, Y. X., PPARs and the complex journey to obesity. Nat. Med. 2004, 10, 355-361.
-
(2004)
Nat. Med.
, vol.10
, pp. 355-361
-
-
Evans, R.M.1
Barish, G.D.2
Wang, Y.X.3
-
28
-
-
33644652183
-
Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis
-
Lefebvre, P., Chinetti, G., Fruchart, J. C., Staels, B., Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006, 116, 571-580.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 571-580
-
-
Lefebvre, P.1
Chinetti, G.2
Fruchart, J.C.3
Staels, B.4
-
29
-
-
40049088000
-
PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
-
Gonzalez, F. J., Shah, Y. M., PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 2008, 246, 2-8.
-
(2008)
Toxicology
, vol.246
, pp. 2-8
-
-
Gonzalez, F.J.1
Shah, Y.M.2
-
30
-
-
34547565746
-
PPARalpha and dyslipidemia
-
Duval, C., Müller, M., Kersten, S., PPARalpha and dyslipidemia. Biochim. Biophys. Acta 2007, 1771, 961-971.
-
(2007)
Biochim. Biophys. Acta
, vol.1771
, pp. 961-971
-
-
Duval, C.1
Müller, M.2
Kersten, S.3
-
31
-
-
0032699670
-
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
-
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J. et al., Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103, 1489-1498.
-
(1999)
J. Clin. Invest.
, vol.103
, pp. 1489-1498
-
-
Kersten, S.1
Seydoux, J.2
Peters, J.M.3
Gonzalez, F.J.4
-
32
-
-
0037184921
-
Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production
-
Xu, J., Xiao, G., Trujillo, C., Chang, V. et al., Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J. Biol. Chem. 2002, 277, 50237-50244.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 50237-50244
-
-
Xu, J.1
Xiao, G.2
Trujillo, C.3
Chang, V.4
-
33
-
-
3242750659
-
PPARalpha governs glycerol metabolism
-
Patsouris, D., Mandard, S., Voshol, P. J., Escher, P. et al., PPARalpha governs glycerol metabolism. J. Clin. Invest. 2004, 114, 94-103.
-
(2004)
J. Clin. Invest.
, vol.114
, pp. 94-103
-
-
Patsouris, D.1
Mandard, S.2
Voshol, P.J.3
Escher, P.4
-
34
-
-
33644664433
-
Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination
-
Tsuchida, A., Yamauchi, T., Takekawa, S., Hada, Y. et al., Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005, 54, 3358-3370.
-
(2005)
Diabetes
, vol.54
, pp. 3358-3370
-
-
Tsuchida, A.1
Yamauchi, T.2
Takekawa, S.3
Hada, Y.4
-
35
-
-
80054956019
-
Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways
-
Goto, T., Kim, Y. I., Funakoshi, K., Teraminami, A. et al., Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E1022-E1032.
-
(2011)
Am. J. Physiol. Endocrinol. Metab.
, vol.301
-
-
Goto, T.1
Kim, Y.I.2
Funakoshi, K.3
Teraminami, A.4
-
36
-
-
0034595980
-
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
-
Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L. et al., Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 2000, 275, 16638-16642.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 16638-16642
-
-
Guerre-Millo, M.1
Gervois, P.2
Raspé, E.3
Madsen, L.4
-
37
-
-
0037025390
-
WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice
-
Chou, C. J., Haluzik, M., Gregory, C., Dietz, K. R. et al., WY14, 643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 2002, 277, 24484-24489.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 24484-24489
-
-
Chou, C.J.1
Haluzik, M.2
Gregory, C.3
Dietz, K.R.4
-
38
-
-
0038353634
-
Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis
-
Kim, H., Haluzik, M., Asghar, Z., Yau, D. et al., Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 2003, 52, 1770-1778.
-
(2003)
Diabetes
, vol.52
, pp. 1770-1778
-
-
Kim, H.1
Haluzik, M.2
Asghar, Z.3
Yau, D.4
-
39
-
-
0035141142
-
Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation
-
Ye, J. M., Doyle, P. J., Iglesias, M. A., Watson, D. G. et al., Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001, 50, 411-417.
-
(2001)
Diabetes
, vol.50
, pp. 411-417
-
-
Ye, J.M.1
Doyle, P.J.2
Iglesias, M.A.3
Watson, D.G.4
-
40
-
-
45549089456
-
A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels
-
Stefanovic-Racic, M., Perdomo, G., Mantell, B. S., Sipula, I. J. et al., A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E969-E977.
-
(2008)
Am. J. Physiol. Endocrinol. Metab.
, vol.294
-
-
Stefanovic-Racic, M.1
Perdomo, G.2
Mantell, B.S.3
Sipula, I.J.4
-
41
-
-
0035317950
-
Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol
-
Szapary, P. O., Rader, D. J., Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr. Opin. Pharmacol. 2001, 1, 113-120.
-
(2001)
Curr. Opin. Pharmacol
, vol.1
, pp. 113-120
-
-
Szapary, P.O.1
Rader, D.J.2
-
42
-
-
0036086512
-
Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production
-
Takahashi, M., Tsuboyama-Kasaoka, N., Nakatani, T., Ishii, M. et al., Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282, G338-G348.
-
(2002)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.282
-
-
Takahashi, M.1
Tsuboyama-Kasaoka, N.2
Nakatani, T.3
Ishii, M.4
-
43
-
-
28844485678
-
Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A Review
-
Lombardo, Y. B., Chicco, A., Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A Review. J. Nutr. Biochem. 2006, 17, 1-13.
-
(2006)
J. Nutr. Biochem.
, vol.17
, pp. 1-13
-
-
Lombardo, Y.B.1
Chicco, A.2
-
44
-
-
0033972318
-
Importance of n-3 fatty acids in health and disease
-
Connor, W. E., Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 2000, 71, 171S-175S.
-
(2000)
Am. J. Clin. Nutr
, vol.71
-
-
Connor, W.E.1
-
45
-
-
31544455792
-
Fatty acid regulation of hepatic gene transcription
-
Jump, D. B., Botolin, D., Wang, Y., Xu, J. et al., Fatty acid regulation of hepatic gene transcription. J. Nutr. 2005, 135, 2503-2506
-
(2005)
J. Nutr.
, vol.135
, pp. 2503-2506
-
-
Jump, D.B.1
Botolin, D.2
Wang, Y.3
Xu, J.4
-
46
-
-
0035066651
-
Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome
-
Clarke, S. D., Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J. Nutr. 2001, 131, 1129-1132.
-
(2001)
J. Nutr.
, vol.131
, pp. 1129-1132
-
-
Clarke, S.D.1
-
47
-
-
0032796505
-
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα
-
Silvia, Y. M. C., John, P. V. H., Steven, G. B., Lisa, A. L. et al., Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα. J. Lipid Res. 1999, 40, 1426-1433.
-
(1999)
J. Lipid Res.
, vol.40
, pp. 1426-1433
-
-
Silvia, Y.M.C.1
John, P.V.H.2
Steven, G.B.3
Lisa, A.L.4
-
48
-
-
0032955643
-
Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice
-
Park, Y., Storkson, J. M., Albright, K. J., Liu, W. et al., Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34, 235-241.
-
(1999)
Lipids
, vol.34
, pp. 235-241
-
-
Park, Y.1
Storkson, J.M.2
Albright, K.J.3
Liu, W.4
-
49
-
-
0035041793
-
Isomerspecific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression
-
Ryder, J. W., Portocarrero, C. P., Song, X. M., Cui, L. et al., Isomerspecific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001, 50, 1149-1157.
-
(2001)
Diabetes
, vol.50
, pp. 1149-1157
-
-
Ryder, J.W.1
Portocarrero, C.P.2
Song, X.M.3
Cui, L.4
-
50
-
-
0038710041
-
Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice
-
Hargrave, K. M., Li, C., Meyer, B. J., Kachman, S. D. et al., Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes. Res. 2002, 10, 1284-1290.
-
(2002)
Obes. Res
, vol.10
, pp. 1284-1290
-
-
Hargrave, K.M.1
Li, C.2
Meyer, B.J.3
Kachman, S.D.4
-
51
-
-
0038678107
-
Isomerspecific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat
-
Henriksen, E. J., Teachey, M. K., Taylor, Z. C., Jacob, S. et al., Isomerspecific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E98-E105.
-
(2003)
Am. J. Physiol. Endocrinol. Metab
, vol.285
-
-
Henriksen, E.J.1
Teachey, M.K.2
Taylor, Z.C.3
Jacob, S.4
-
52
-
-
0032899791
-
Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid
-
Park, Y., Albright, K. J., Storkson, J. M., Liu, W. et al., Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 1999, 34, 243-248.
-
(1999)
Lipids
, vol.34
, pp. 243-248
-
-
Park, Y.1
Albright, K.J.2
Storkson, J.M.3
Liu, W.4
-
53
-
-
0036195963
-
Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes
-
Evans, M., Lin, X., Odle, J., McIntosh, M., Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes. J. Nutr. 2002, 132, 450-455.
-
(2002)
J. Nutr
, vol.132
, pp. 450-455
-
-
Evans, M.1
Lin, X.2
Odle, J.3
McIntosh, M.4
-
54
-
-
0031708155
-
Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse
-
West, D. B., Delany, J. P., Camet, P. M., Blohm, F. et al., Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 1998, 275, R667-R672.
-
(1998)
Am. J. Physiol
, vol.275
-
-
West, D.B.1
Delany, J.P.2
Camet, P.M.3
Blohm, F.4
-
55
-
-
0034858073
-
Trans-10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue
-
Brown, J. M., Halvorsen, Y. D., Lea-Currie, Y. R., Geigerman, C. et al., Trans-10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J. Nutr. 2001, 131, 2316-2321.
-
(2001)
J. Nutr
, vol.131
, pp. 2316-2321
-
-
Brown, J.M.1
Halvorsen, Y.D.2
Lea-Currie, Y.R.3
Geigerman, C.4
-
56
-
-
0037432675
-
Trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPARγ expression
-
Kang, K., Liu, W., Albright, K. J., Park, Y. et al., Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPARγ expression. Biochem. Biophys. Res. Commun. 2003, 303, 795-799.
-
(2003)
Biochem. Biophys. Res. Commun
, vol.303
, pp. 795-799
-
-
Kang, K.1
Liu, W.2
Albright, K.J.3
Park, Y.4
-
57
-
-
79953297693
-
9-oxo-10(E),12(E)- octadecadienoic acid derived from tomato is a potent peroxisome proliferator-activated receptor α agonist to decrease triglyceride accumulation in mouse primary hepatocytes
-
Kim, Y. I., Hirai, S., Takahashi, H., Goto, T. et al., 9-oxo-10(E), 12(E)- octadecadienoic acid derived from tomato is a potent peroxisome proliferator-activated receptor α agonist to decrease triglyceride accumulation in mouse primary hepatocytes. Mol. Nutr. Food Res. 2011, 55, 585-593.
-
(2011)
Mol. Nutr. Food Res.
, vol.55
, pp. 585-593
-
-
Kim, Y.I.1
Hirai, S.2
Takahashi, H.3
Goto, T.4
-
58
-
-
84863011904
-
Potent PPARα activator derived from tomato juice, 13-oxo-9,11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice
-
Kim, Y. I., Hirai, S., Goto, T., Ohyane, C. et al., Potent PPARα activator derived from tomato juice, 13-oxo-9, 11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice. PLoS One 2012, 7, e31317.
-
(2012)
PLoS One
, vol.7
-
-
Kim, Y.I.1
Hirai, S.2
Goto, T.3
Ohyane, C.4
-
59
-
-
26444457309
-
Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes
-
Goto, T., Takahashi, N., Kato, S., Egawa, K. et al., Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes. Biochem. Biophys. Res. Commun. 2005, 337, 440-444.
-
(2005)
Biochem. Biophys. Res. Commun
, vol.337
, pp. 440-444
-
-
Goto, T.1
Takahashi, N.2
Kato, S.3
Egawa, K.4
-
60
-
-
13544270873
-
Antitumor-promoting activity of coumarins from citrus plants
-
Ito, C., Itoigawa, M., Ju-ichi, M., Sakamoto, N. et al., Antitumor-promoting activity of coumarins from citrus plants. Planta Med. 2005, 71, 84-87.
-
(2005)
Planta Med.
, vol.71
, pp. 84-87
-
-
Ito, C.1
Itoigawa, M.2
Ju-ichi, M.3
Sakamoto, N.4
-
61
-
-
15544387131
-
Food consumption and the incidence of type II diabetes mellitus
-
Montonen, J., Jervinen, R., Heliovaara, M., Reunanen, A. et al., Food consumption and the incidence of type II diabetes mellitus. Eur. J. Clin. Nutr. 2005, 59, 441-448.
-
(2005)
Eur. J. Clin. Nutr.
, vol.59
, pp. 441-448
-
-
Montonen, J.1
Jervinen, R.2
Heliovaara, M.3
Reunanen, A.4
-
62
-
-
65449152857
-
Auraptene, a citrus fruit compound, regulates gene expression as a PPARα agonist in HepG2 hepatocytes
-
Takahashi, N., Kang, M. S., Kuroyanagi, K., Goto, T. et al., Auraptene, a citrus fruit compound, regulates gene expression as a PPARα agonist in HepG2 hepatocytes. BioFactors 2008, 33, 25-32.
-
(2008)
BioFactors
, vol.33
, pp. 25-32
-
-
Takahashi, N.1
Kang, M.S.2
Kuroyanagi, K.3
Goto, T.4
-
63
-
-
37549021158
-
Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes
-
Kuroyanagi, K., Kang, M. S., Goto, T., Hirai, S. et al., Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 366, 219-225.
-
(2008)
Biochem. Biophys. Res. Commun
, vol.366
, pp. 219-225
-
-
Kuroyanagi, K.1
Kang, M.S.2
Goto, T.3
Hirai, S.4
-
64
-
-
82955170675
-
Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice
-
Takahashi, N., Senda, M., Lin, S., Goto, T. et al., Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Mol. Nutr. Food Res. 2011, 55, 1791-1797.
-
(2011)
Mol. Nutr. Food Res.
, vol.55
, pp. 1791-1797
-
-
Takahashi, N.1
Senda, M.2
Lin, S.3
Goto, T.4
-
65
-
-
78651560987
-
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice
-
Uchida, A., Slipchenko, M. N., Cheng, J. X., Buhman, K. K., Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice. Biochim. Biophys. Acta 2011, 1811, 170-176.
-
(2011)
Biochim. Biophys. Acta
, vol.1811
, pp. 170-176
-
-
Uchida, A.1
Slipchenko, M.N.2
Cheng, J.X.3
Buhman, K.K.4
-
66
-
-
79959373746
-
Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes
-
Kimura, R., Takahashi, N., Murota, K., Yamada, Y. et al., Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes. Biochem. Biophys. Res. Commun. 2011, 410, 1-6.
-
(2011)
Biochem. Biophys. Res. Commun
, vol.410
, pp. 1-6
-
-
Kimura, R.1
Takahashi, N.2
Murota, K.3
Yamada, Y.4
-
67
-
-
28944446431
-
The many faces of PPARgamma
-
Lehrke, M., Lazar, M. A., The many faces of PPARgamma. Cell 2005, 123, 993-999.
-
(2005)
Cell
, vol.123
, pp. 993-999
-
-
Lehrke, M.1
Lazar, M.A.2
-
68
-
-
50649097541
-
Fat and beyond: the diverse biology of PPARgamma
-
Tontonoz, P., Spiegelman, B. M., Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77, 289-312.
-
(2008)
Annu. Rev. Biochem.
, vol.77
, pp. 289-312
-
-
Tontonoz, P.1
Spiegelman, B.M.2
-
69
-
-
34447618831
-
PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
-
Ahmed, W., Ziouzenkova, O., Brown, J., Devchand, P. et al., PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J. Intern. Med. 2007, 262, 184-198.
-
(2007)
J. Intern. Med.
, vol.262
, pp. 184-198
-
-
Ahmed, W.1
Ziouzenkova, O.2
Brown, J.3
Devchand, P.4
-
70
-
-
0036007025
-
PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis
-
Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P. et al., PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 2002, 16, 27-32.
-
(2002)
Genes Dev.
, vol.16
, pp. 27-32
-
-
Ren, D.1
Collingwood, T.N.2
Rebar, E.J.3
Wolffe, A.P.4
-
71
-
-
0036007024
-
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway
-
Rosen, E. D., Hsu, C. H., Wang, X., Sakai, S. et al., C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16, 22-26.
-
(2002)
Genes Dev.
, vol.16
, pp. 22-26
-
-
Rosen, E.D.1
Hsu, C.H.2
Wang, X.3
Sakai, S.4
-
72
-
-
35148837113
-
GLAI Study, Investigators. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
-
Deeg, M. A., Buse, J. B., Goldberg, R. B., Kendall, D. M. et al., GLAI Study, Investigators. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2007, 30, 2458-2464.
-
(2007)
Diabetes Care
, vol.30
, pp. 2458-2464
-
-
Deeg, M.A.1
Buse, J.B.2
Goldberg, R.B.3
Kendall, D.M.4
-
73
-
-
0037330414
-
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
-
Larsen, T. M., Toubro, S., Astrup, A., PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int. J. Obes. Relat. Metab. Disord. 2003, 27, 147-161.
-
(2003)
Int. J. Obes. Relat. Metab. Disord.
, vol.27
, pp. 147-161
-
-
Larsen, T.M.1
Toubro, S.2
Astrup, A.3
-
74
-
-
58849102970
-
Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator
-
van Beekum, O., Fleskens, V., Kalkhoven, E., Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator. Obesity 2009, 17, 213-219.
-
(2009)
Obesity
, vol.17
, pp. 213-219
-
-
van Beekum, O.1
Fleskens, V.2
Kalkhoven, E.3
-
75
-
-
45449083221
-
Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1
-
Chung, S. S., Kim, J. H., Park, H. S., Choi, H. H. et al., Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1. Biochem. Biophys. Res. Commun. 2008, 372, 713-718.
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.372
, pp. 713-718
-
-
Chung, S.S.1
Kim, J.H.2
Park, H.S.3
Choi, H.H.4
-
76
-
-
0141920726
-
Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity
-
Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S. et al., Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev. Cell. 2003, 5, 657-663.
-
(2003)
Dev. Cell.
, vol.5
, pp. 657-663
-
-
Rangwala, S.M.1
Rhoades, B.2
Shapiro, J.S.3
Rich, A.S.4
-
77
-
-
77954941113
-
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5
-
Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S. et al., Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010, 466, 451-456.
-
(2010)
Nature
, vol.466
, pp. 451-456
-
-
Choi, J.H.1
Banks, A.S.2
Estall, J.L.3
Kajimura, S.4
-
78
-
-
80053131732
-
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
-
Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A. et al., Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. Nature 2011, 477, 477-481.
-
(2011)
Nature
, vol.477
, pp. 477-481
-
-
Choi, J.H.1
Banks, A.S.2
Kamenecka, T.M.3
Busby, S.A.4
-
79
-
-
81055144760
-
Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity
-
Li, P., Fan, W., Xu, J., Lu, M. et al., Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell 2011, 147, 815-826.
-
(2011)
Cell
, vol.147
, pp. 815-826
-
-
Li, P.1
Fan, W.2
Xu, J.3
Lu, M.4
-
80
-
-
0242559065
-
To dye or not to dye: biochemistry of annatto unveiled
-
Giuliano, G., Rosati, C., Bramley, P. M., To dye or not to dye: biochemistry of annatto unveiled. Trends Biotechnol. 2003, 21, 513-516.
-
(2003)
Trends Biotechnol.
, vol.21
, pp. 513-516
-
-
Giuliano, G.1
Rosati, C.2
Bramley, P.M.3
-
81
-
-
0037933420
-
Biosynthesis of the food and cosmetic plant pigment bixin (annatto)
-
Bouvier, F., Dogbo, O., Camara, B., Biosynthesis of the food and cosmetic plant pigment bixin (annatto). Science 2003, 300, 2089-2091.
-
(2003)
Science
, vol.300
, pp. 2089-2091
-
-
Bouvier, F.1
Dogbo, O.2
Camara, B.3
-
82
-
-
0141851183
-
Dietary supplementation with a natural carotenoid mixture decreases oxidative stress
-
Kiokias, S., Gordon, M. H., Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. Eur. J. Clin. Nutr. 2003, 57, 1135-1140.
-
(2003)
Eur. J. Clin. Nutr.
, vol.57
, pp. 1135-1140
-
-
Kiokias, S.1
Gordon, M.H.2
-
83
-
-
28444440307
-
Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors
-
Reddy, M. K., Alexander-Lindo, R. L., Nair, M. G., Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors. J. Agric. Food Chem. 2005, 53, 9268-9273.
-
(2005)
J. Agric. Food Chem.
, vol.53
, pp. 9268-9273
-
-
Reddy, M.K.1
Alexander-Lindo, R.L.2
Nair, M.G.3
-
84
-
-
0034931627
-
Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats
-
Silva, C. R., Antunes, L. M., Bianchi, M. L., Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. Pharmacol. Res. 2001, 43, 561-566.
-
(2001)
Pharmacol. Res.
, vol.43
, pp. 561-566
-
-
Silva, C.R.1
Antunes, L.M.2
Bianchi, M.L.3
-
85
-
-
52649177657
-
Hypoglycaemic activity of Bixa orellana extract in the dog
-
Russell, K. R., Omoruyi, F. O., Pascoe, K. O., Morrison, E. Y., Hypoglycaemic activity of Bixa orellana extract in the dog. Methods Find. Exp. Clin. Pharmacol. 2008, 30, 301-305.
-
(2008)
Methods Find. Exp. Clin. Pharmacol.
, vol.30
, pp. 301-305
-
-
Russell, K.R.1
Omoruyi, F.O.2
Pascoe, K.O.3
Morrison, E.Y.4
-
86
-
-
0036307869
-
Norbixin ingestion did not induce any detectable DNA breakage in liver and kidney but caused a considerable impairment in plasma glucose levels of rats and mice
-
Fernandes, A. C., Almeida, C. A., Albano, F., Laranja, G. A. et al., Norbixin ingestion did not induce any detectable DNA breakage in liver and kidney but caused a considerable impairment in plasma glucose levels of rats and mice. J. Nutr. Biochem. 2002, 13, 411-420.
-
(2002)
J. Nutr. Biochem.
, vol.13
, pp. 411-420
-
-
Fernandes, A.C.1
Almeida, C.A.2
Albano, F.3
Laranja, G.A.4
-
87
-
-
70450257641
-
Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation
-
Takahashi, N., Goto, T., Taimatsu, A., Egawa, K. et al., Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation. Biochem. Biophys. Res. Commun. 2009, 390, 1372-1376.
-
(2009)
Biochem. Biophys. Res. Commun
, vol.390
, pp. 1372-1376
-
-
Takahashi, N.1
Goto, T.2
Taimatsu, A.3
Egawa, K.4
-
88
-
-
0029912852
-
Flavonoids activate wild-type p53
-
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G. et al., Flavonoids activate wild-type p53. Oncogene 1996, 13, 1605-1614.
-
(1996)
Oncogene
, vol.13
, pp. 1605-1614
-
-
Plaumann, B.1
Fritsche, M.2
Rimpler, H.3
Brandner, G.4
-
89
-
-
0030741461
-
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
-
Fotsis, T., Pepper, M. S., Aktas, E., Breit, S. et al., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57, 2916-2921.
-
(1997)
Cancer Res.
, vol.57
, pp. 2916-2921
-
-
Fotsis, T.1
Pepper, M.S.2
Aktas, E.3
Breit, S.4
-
90
-
-
0031831117
-
Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay
-
Breinholt, V., Larsen, J. C., Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol. 1998, 11, 622-629.
-
(1998)
Chem. Res. Toxicol.
, vol.11
, pp. 622-629
-
-
Breinholt, V.1
Larsen, J.C.2
-
91
-
-
0034996015
-
Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis
-
Harmon, A. W., Harp, J. B., Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J. Physiol. Cell Physiol. 2001, 280, C807-C813.
-
(2001)
Am. J. Physiol. Cell Physiol.
, vol.280
-
-
Harmon, A.W.1
Harp, J.B.2
-
92
-
-
0035805144
-
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages
-
Liang, Y. C., Tsai, S. H., Tsai, D. C., Lin-Shiau, S. Y. et al., Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett. 2001, 496, 12-18.
-
(2001)
FEBS Lett.
, vol.496
, pp. 12-18
-
-
Liang, Y.C.1
Tsai, S.H.2
Tsai, D.C.3
Lin-Shiau, S.Y.4
-
93
-
-
0031936521
-
Evolution of the health benefits of soy isoflavones
-
Barnes, S., Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med. 1998, 217, 386-392.
-
(1998)
Proc. Soc. Exp. Biol. Med.
, vol.217
, pp. 386-392
-
-
Barnes, S.1
-
94
-
-
0037428403
-
Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein
-
Dang, Z. C., Audinot, V., Papapoulos, S. E., Boutin, J. A. et al., Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 2003, 278, 962-967.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 962-967
-
-
Dang, Z.C.1
Audinot, V.2
Papapoulos, S.E.3
Boutin, J.A.4
-
95
-
-
0033212964
-
PPARgamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
-
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H. et al., PPARgamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 1999, 4, 597-609.
-
(1999)
Mol. Cell.
, vol.4
, pp. 597-609
-
-
Kubota, N.1
Terauchi, Y.2
Miki, H.3
Tamemoto, H.4
-
96
-
-
33644645013
-
PPAR delta: a dagger in the heart of the metabolic syndrome
-
Barish, G. D., Narkar, V. A., Evans, R. M., PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 2006, 116, 590-597.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 590-597
-
-
Barish, G.D.1
Narkar, V.A.2
Evans, R.M.3
-
97
-
-
70349111436
-
Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation
-
Bishop-Bailey, D., Bystrom, J., Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation. Pharmacol. Ther. 2009, 124, 141-150.
-
(2009)
Pharmacol. Ther.
, vol.124
, pp. 141-150
-
-
Bishop-Bailey, D.1
Bystrom, J.2
-
98
-
-
34547136480
-
New therapeutic target for metabolic syndrome: PPARdelta
-
Takahashi, S., Tanaka, T., Sakai, J., New therapeutic target for metabolic syndrome: PPARdelta. Endocr. J. 2007, 54, 347-357.
-
(2007)
Endocr. J.
, vol.54
, pp. 347-357
-
-
Takahashi, S.1
Tanaka, T.2
Sakai, J.3
-
99
-
-
41949123156
-
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
-
Takata, Y., Liu, J., Yin, F., Collins, A. R. et al., PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc. Natl. Acad. Sci. USA 2008, 105, 4277-4282.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 4277-4282
-
-
Takata, Y.1
Liu, J.2
Yin, F.3
Collins, A.R.4
-
100
-
-
0035942162
-
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
-
Oliver, W. R., Jr., Shenk, J. L., Snaith, M. R., Russell, C. S. et al., A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 2001, 98, 5306-5311.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 5306-5311
-
-
Oliver Jr, W.R.1
Shenk, J.L.2
Snaith, M.R.3
Russell, C.S.4
-
101
-
-
22344449773
-
Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1
-
van der Veen, J. N., Kruit, J. K., Havinga, R., Baller, J. F. et al., Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J. Lipid Res. 2005, 46, 526-534.
-
(2005)
J. Lipid Res.
, vol.46
, pp. 526-534
-
-
van der Veen, J.N.1
Kruit, J.K.2
Havinga, R.3
Baller, J.F.4
-
102
-
-
20444378931
-
The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice
-
Graham, T. L., Mookherjee, C., Suckling, K. E., Palmer, C. N. et al., The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis 2005, 181, 29-37.
-
(2005)
Atherosclerosis
, vol.181
, pp. 29-37
-
-
Graham, T.L.1
Mookherjee, C.2
Suckling, K.E.3
Palmer, C.N.4
-
103
-
-
85047693466
-
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma
-
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K. et al., Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 2004, 114, 1564-1576.
-
(2004)
J. Clin. Invest.
, vol.114
, pp. 1564-1576
-
-
Li, A.C.1
Binder, C.J.2
Gutierrez, A.3
Brown, K.K.4
-
104
-
-
0142116239
-
Transcriptional repression of atherogenic inflammation: modulation by PPARdelta
-
Lee, C. H., Chawla, A., Urbiztondo, N., Liao, D. et al., Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 2003, 302, 453-457.
-
(2003)
Science
, vol.302
, pp. 453-457
-
-
Lee, C.H.1
Chawla, A.2
Urbiztondo, N.3
Liao, D.4
-
105
-
-
41949123156
-
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
-
Takata, Y., Liu, J., Yin, F., Collins, A. R. et al., PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc. Natl. Acad. Sci. USA 2008, 105, 4277-4282.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 4277-4282
-
-
Takata, Y.1
Liu, J.2
Yin, F.3
Collins, A.R.4
-
106
-
-
77649303444
-
Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors
-
Fang, F., Kang, Z., Wong, C., Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol. Nutr. Food Res. 2010, 54, 345-352.
-
(2010)
Mol. Nutr. Food Res.
, vol.54
, pp. 345-352
-
-
Fang, F.1
Kang, Z.2
Wong, C.3
-
107
-
-
84859154579
-
An ethanol extract of Artemisia iwayomogi activates PPARδ leading to activation of fatty acid oxidation in skeletal muscle
-
Cho, S. Y., Jeong, H. W., Sohn, J. H., Seo, D. B. et al., An ethanol extract of Artemisia iwayomogi activates PPARδ leading to activation of fatty acid oxidation in skeletal muscle. PLoS One 2012, 7, e33815.
-
(2012)
PLoS One
, vol.7
-
-
Cho, S.Y.1
Jeong, H.W.2
Sohn, J.H.3
Seo, D.B.4
-
108
-
-
69849105712
-
Green tea extract selectively activates peroxisome proliferator-activated receptor beta/delta in cultured cardiomyocytes
-
Danesi, F., Di Nunzio, M., Boschetti, E., Bordoni, A., Green tea extract selectively activates peroxisome proliferator-activated receptor beta/delta in cultured cardiomyocytes. Br. J. Nutr. 2009, 101, 1736-1739.
-
(2009)
Br. J. Nutr.
, vol.101
, pp. 1736-1739
-
-
Danesi, F.1
Di Nunzio, M.2
Boschetti, E.3
Bordoni, A.4
-
109
-
-
77950361055
-
Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta
-
Sasa, M., Inoue, I., Shinoda, Y., Takahashi, S. et al., Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta. J. Atheroscler. Thromb. 2009, 16, 888-892.
-
(2009)
J. Atheroscler. Thromb.
, vol.16
, pp. 888-892
-
-
Sasa, M.1
Inoue, I.2
Shinoda, Y.3
Takahashi, S.4
-
110
-
-
0142149220
-
Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta
-
Shaw, N., Elholm, M., Noy, N., Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. J. Biol. Chem. 2003, 278, 41589-41592.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 41589-41592
-
-
Shaw, N.1
Elholm, M.2
Noy, N.3
-
111
-
-
34249087361
-
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
-
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N. et al., Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129, 723-733.
-
(2007)
Cell
, vol.129
, pp. 723-733
-
-
Schug, T.T.1
Berry, D.C.2
Shaw, N.S.3
Travis, S.N.4
-
112
-
-
67649211584
-
All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor
-
Berry, D. C., Noy, N., All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol. Cell. Biol. 2009, 29, 3286-3296.
-
(2009)
Mol. Cell. Biol.
, vol.29
, pp. 3286-3296
-
-
Berry, D.C.1
Noy, N.2
-
113
-
-
33644651160
-
Liver X receptors as integrators of metabolic and inflammatory signaling
-
Zelcer, N., Tontonoz, P., Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 2006, 116, 607-614.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 607-614
-
-
Zelcer, N.1
Tontonoz, P.2
-
114
-
-
23744466617
-
Gaining weight: the Keystone Symposium on PPAR and LXR
-
Lehrke, M., Pascual, G., Glass, C. K., Lazar, M. A., Gaining weight: the Keystone Symposium on PPAR and LXR. Genes Dev. 2005, 19, 1737-1742.
-
(2005)
Genes Dev.
, vol.19
, pp. 1737-1742
-
-
Lehrke, M.1
Pascual, G.2
Glass, C.K.3
Lazar, M.A.4
-
115
-
-
33645983221
-
LXRs and FXR: the yin and yang of cholesterol and fat metabolism
-
Kalaany, N. Y., Mangelsdorf, D. J., LXRs and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 2006, 68, 159-191.
-
(2006)
Annu. Rev. Physiol.
, vol.68
, pp. 159-191
-
-
Kalaany, N.Y.1
Mangelsdorf, D.J.2
-
116
-
-
74549224652
-
The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist
-
Kumar, N., Solt, L. A., Conkright, J. J., Wang, Y. et al., The benzenesulfoamide T0901317 [N-(2, 2, 2-trifluoroethyl)-N-[4-[2, 2, 2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol. Pharmacol. 2010, 77, 228-236.
-
(2010)
Mol. Pharmacol.
, vol.77
, pp. 228-236
-
-
Kumar, N.1
Solt, L.A.2
Conkright, J.J.3
Wang, Y.4
-
117
-
-
4744354632
-
T0901317 is a dual LXR/FXR agonist
-
Houck, K. A., Borchert, K. M., Hepler, C. D., Thomas, J. S. et al., T0901317 is a dual LXR/FXR agonist. Mol. Genet. Metab. 2004, 83, 184-187.
-
(2004)
Mol. Genet. Metab.
, vol.83
, pp. 184-187
-
-
Houck, K.A.1
Borchert, K.M.2
Hepler, C.D.3
Thomas, J.S.4
-
118
-
-
34247093820
-
T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR
-
Mitro, N., Vargas, L., Romeo, R., Koder, A. et al., T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett. 2007, 581, 1721-1726.
-
(2007)
FEBS Lett.
, vol.581
, pp. 1721-1726
-
-
Mitro, N.1
Vargas, L.2
Romeo, R.3
Koder, A.4
-
119
-
-
0034710965
-
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha
-
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A. et al., Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 2000, 97, 12097-12102.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 12097-12102
-
-
Venkateswaran, A.1
Laffitte, B.A.2
Joseph, S.B.3
Mak, P.A.4
-
120
-
-
30444447387
-
Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype
-
Lund, E. G., Peterson, L. B., Adams, A. D., Lam, M. H. et al., Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Biochem. Pharmacol. 2006, 71, 453-463.
-
(2006)
Biochem. Pharmacol.
, vol.71
, pp. 453-463
-
-
Lund, E.G.1
Peterson, L.B.2
Adams, A.D.3
Lam, M.H.4
-
121
-
-
0034669025
-
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
-
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. et al., Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 2000, 14, 2819-2830.
-
(2000)
Genes Dev.
, vol.14
, pp. 2819-2830
-
-
Repa, J.J.1
Liang, G.2
Ou, J.3
Bashmakov, Y.4
-
122
-
-
0035047709
-
Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter
-
Yoshikawa, T., Shimano, H., Amemiya-Kudo, M., Yahagi, N. et al., Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 2001, 21, 2991-3000.
-
(2001)
Mol. Cell. Biol.
, vol.21
, pp. 2991-3000
-
-
Yoshikawa, T.1
Shimano, H.2
Amemiya-Kudo, M.3
Yahagi, N.4
-
123
-
-
34547652884
-
Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE
-
Bradley, M. N., Hong, C., Chen, M., Joseph, S. B. et al., Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J. Clin. Invest. 2007, 117, 2337-2346.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 2337-2346
-
-
Bradley, M.N.1
Hong, C.2
Chen, M.3
Joseph, S.B.4
-
124
-
-
0037296088
-
Therapeutic applications of fenugreek
-
Basch, E., Ulbricht, C., Kuo, G., Szapary, P. et al., Therapeutic applications of fenugreek. Altern. Med. Rev. 2003, 8, 20-27.
-
(2003)
Altern. Med. Rev.
, vol.8
, pp. 20-27
-
-
Basch, E.1
Ulbricht, C.2
Kuo, G.3
Szapary, P.4
-
125
-
-
0022506097
-
Antidiabetic effects of subtractions from fenugreek seeds in diabetic dogs
-
Ribes, G., Sauvaire, Y., Da Costa, C., Baccou, J. C. et al., Antidiabetic effects of subtractions from fenugreek seeds in diabetic dogs. Proc. Soc. Exp. Biol. Med. 1986, 182, 159-166.
-
(1986)
Proc. Soc. Exp. Biol. Med.
, vol.182
, pp. 159-166
-
-
Ribes, G.1
Sauvaire, Y.2
Da Costa, C.3
Baccou, J.C.4
-
126
-
-
0024459216
-
Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice
-
Swanston-Flatt, S. K., Day, C., Flatt, P. R., Gould, B. J. et al., Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 1989, 10, 69-73.
-
(1989)
Diabetes Res.
, vol.10
, pp. 69-73
-
-
Swanston-Flatt, S.K.1
Day, C.2
Flatt, P.R.3
Gould, B.J.4
-
127
-
-
0036000246
-
Medicinal plants of India with anti-diabetic potential
-
Grover, J. K., Yadav, S., Vats, V., Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002, 81, 81-100.
-
(2002)
J. Ethnopharmacol.
, vol.81
, pp. 81-100
-
-
Grover, J.K.1
Yadav, S.2
Vats, V.3
-
128
-
-
0023025947
-
Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human subjects
-
Sharma, R. D., Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human subjects. Nutr. Res. 1986, 6, 1353-1364.
-
(1986)
Nutr. Res
, vol.6
, pp. 1353-1364
-
-
Sharma, R.D.1
-
129
-
-
78650498453
-
Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice
-
Uemura, T., Goto, T., Kang, M. S., Mizoguchi, N. et al., Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 2011, 141, 17-23.
-
(2011)
J. Nutr.
, vol.141
, pp. 17-23
-
-
Uemura, T.1
Goto, T.2
Kang, M.S.3
Mizoguchi, N.4
-
130
-
-
77954014957
-
Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages
-
Hirai, S., Uemura, T., Mizoguchi, N., Lee, J. Y. et al., Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages. Mol. Nutr. Food Res. 2010, 54, 797-804.
-
(2010)
Mol. Nutr. Food Res
, vol.54
, pp. 797-804
-
-
Hirai, S.1
Uemura, T.2
Mizoguchi, N.3
Lee, J.Y.4
-
131
-
-
78349261237
-
Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues
-
Uemura, T., Hirai, S., Mizoguchi, N., Goto, T. et al., Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol. Nutr. Food Res. 2010, 54, 1596-608.
-
(2010)
Mol. Nutr. Food Res
, vol.54
, pp. 1596-1608
-
-
Uemura, T.1
Hirai, S.2
Mizoguchi, N.3
Goto, T.4
-
132
-
-
0037205046
-
A natural product that lowers cholesterol as an antagonist ligand for FXR
-
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V. et al., A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002, 296, 1703-1706.
-
(2002)
Science
, vol.296
, pp. 1703-1706
-
-
Urizar, N.L.1
Liverman, A.B.2
Dodds, D.T.3
Silva, F.V.4
-
133
-
-
0042666932
-
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
-
Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D. et al., Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 2003, 125, 544-555.
-
(2003)
Gastroenterology
, vol.125
, pp. 544-555
-
-
Claudel, T.1
Inoue, Y.2
Barbier, O.3
Duran-Sandoval, D.4
-
134
-
-
85047694456
-
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
-
Watanabe, M., Houten, S. M., Wang, L., Moschetta, A. et al., Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 2004, 113, 1408-1418.
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 1408-1418
-
-
Watanabe, M.1
Houten, S.M.2
Wang, L.3
Moschetta, A.4
-
135
-
-
13844280404
-
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
-
Savkur, R. S., Bramlett, K. S., Michael, L. F., Burris, T. P., Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor. Biochem. Biophys. Res. Commun. 2005, 329, 391-396.
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.329
, pp. 391-396
-
-
Savkur, R.S.1
Bramlett, K.S.2
Michael, L.F.3
Burris, T.P.4
-
136
-
-
32244447570
-
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
-
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H. et al., Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. USA 2006, 103, 1006-1011.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 1006-1011
-
-
Zhang, Y.1
Lee, F.Y.2
Barrera, G.3
Lee, H.4
-
137
-
-
33645531297
-
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
-
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk et al., The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J. Biol. Chem. 2006, 281, 11039-11049.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 11039-11049
-
-
Cariou, B.1
van Harmelen, K.2
Duran-Sandoval, D.3
van Dijk4
-
138
-
-
22544474215
-
Transient impairment of the adaptive response to fasting in FXR-deficient mice
-
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. et al., Transient impairment of the adaptive response to fasting in FXR-deficient mice. FEBS Lett. 2005, 579, 4076-4080.
-
(2005)
FEBS Lett.
, vol.579
, pp. 4076-4080
-
-
Cariou, B.1
van Harmelen, K.2
Duran-Sandoval, D.3
van Dijk, T.4
-
139
-
-
79960695556
-
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure
-
Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K. et al., Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J. Biol. Chem. 2011, 286, 26913-26920.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 26913-26920
-
-
Watanabe, M.1
Horai, Y.2
Houten, S.M.3
Morimoto, K.4
-
140
-
-
37249092686
-
Scalarane sesterterpenes fromamarine sponge of the genus Spongia and their FXR antagonistic activity
-
Nam, S. J., Ko, H., Ju, M. K., Hwang, H. et al., Scalarane sesterterpenes fromamarine sponge of the genus Spongia and their FXR antagonistic activity. J. Nat. Prod. 2007, 70, 1691-1695.
-
(2007)
J. Nat. Prod.
, vol.70
, pp. 1691-1695
-
-
Nam, S.J.1
Ko, H.2
Ju, M.K.3
Hwang, H.4
|